ABNOM
☆ AI Dermatology — Free Service
2022 ۾ جرمني مان Stiftung Warentest نتيجن، ModelDerm سان صارفين جي اطمينان صرف ادا ڪيل ٽيلي ميڊيسن مشوري جي ڀيٽ ۾ ٿورو گهٽ هئي.
2022 ۾ جرمني مان Stiftung Warentest نتيجن، ModelDerm سان صارفين جي اطمينان صرف ادا ڪيل ٽيلي ميڊيسن مشوري جي ڀيٽ ۾ ٿورو گهٽ هئي.
relevance score : -100.0%
ReferencesQ‑switched Nd:YAG ليزر اوٽا جي نيويوس ۽ ساڳئي حالتن کي مؤثر طريقي سان علاج ڪرڻ لاءِ سڃاتو ويندو آهي. اسان هڪ مطالعو ڪيو ته ڏسجي ته ڪيئن high‑fluence 1064 nm Q‑switched Nd:YAG ليزر غير معمولي علائقن ۾ منگوليا جي جڳهن تي ڪم ڪري ٿو، بغير چمڙي کي روشن ڪرڻ جي. اسان 61 مريضن جو جائزو ورتو، جن ۾ مجموعي طور تي 70 زخمن شامل هئا. اڌ زخمن جو علاج ليزر سان ڪيو ويو، جڏهن ته باقي زخمن کي ڪنٽرول گروپ طور بغير علاج رکيو ويو. نتيجن جي جائزي لاءِ اسان Mexameter® نالي ڊيوائس استعمال ڪئي، جيڪا ميلانين جي سطح ماپڻ لاءِ استعمال ٿيندي آهي. مريضن جي اوسط پيروي 14 مهينا علاج گروپ ۽ 18 مهينا مشاهدي گروپ ۾ ڪئي وئي. مطالعي جي آخر ۾، علاج ٿيل ۽ غير علاج ٿيل گروپن جي پيماني اسڪور ۽ ميلانين جي سطح ۾ اهم فرق ڏسڻ ۾ آيو، جتي ليزر‑علاج ٿيل گروپ بهتر نتيجا ڏيکاري. high‑fluence Q‑switched Nd:YAG ليزر، چمڙي جي روشنيءَ جو سبب بڻجڻ کان سواءِ، انهن غير معمولي منگولين جڳهن جي علاج لاءِ اثرائتو ۽ محفوظ ثابت ٿيو.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
اسان ABNOM لاءِ مخصوص ليزر علاج جي اثرائتي ۽ حفاظت جو مطالعو ڪيو، ۽ ڏٺو ته ڪهڙا عنصر اثرانداز ٿي سگهن ٿا ۽ اهو ڪيئن ڪم ڪري ٿو. اسان 110 مريضن جو جائزو ورتو جن کي ABNOM تشخيص ٿيل هو ۽ جن کي ٻه يا نو ليزر سيشن مليا. اسان محسوس ڪيو ته علاج بهتر ڪم ڪيو، خاص طور تي ڊگهي مدت ۾، پر پراڻن مريضن ۾ اهو اثر گهٽ هو. اهو خاص طور تي هلڪي چمڙي (قسم III) ۽ ننڍن متاثر علائقن (10 cm² کان گهٽ) ۾ بهتر ڪم ڪيو. Melasma سان گڏ ABNOM علاج جي اثرائتي گهٽجي وئي. متاثر ٿيل علائقن جو رنگ يا تعداد اثرانداز نه ٿيو. تقريباً 10 ٪ مريضن ۾ علاج کان پوءِ اونداهي داغ ظاهر ٿيا. شروعات ۾ ڪيترن ئي مريضن کي سٺو نتيجو مليو. اونداهي جلد يا اڳ ۾ اونداهي داغن وارا مريض علاج کان پوءِ وڌيڪ ڪارا داغن جي وڌيڪ امڪان رکن ٿا. ABNOM ۽ Melasma سان مريضن لاءِ، گهٽ توانائي وارو ليزر استعمال ڪرڻ بهتر آهي ته جيئن Melasma جي خراب ٿيڻ کان بچي سگهجي.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ علاج
اڇو ڪندڙ ايجنٽ تمام گهٽ مددگار ثابت ٿيندا آهن. ميلاسما جي برعڪس، ABNOM کي ليزر جي علاج سان بهتر ڪري سگهجي ٿو ۽ ٻيهر ظاهر ٿيڻ کان بچائي سگهجي ٿو. ABNOM جي علاج لاءِ ليزر سيشن 10 کان 20 ڀيرا تائين ڪري سگهجن ٿا.
#QS1064 laser